Staff Profile

Dr Geoffrey Bellingan

Photo

Personal Profile

Name: Geoffrey Bellingan Email: g.bellingan@ucl.ac.uk
Title: Dr Tel:
Department: Clinical Physiology Fax:
Position: Reader in Intensive Care Medicine Address: , , ,
Research Domain: Web Page:  

Profile

Research Description


Research Activities

Critical Care Medicine

Understaning the cellular players and soluble medi

critical care

Education Description

UCL Collaborators

Dr Mike Grocott; Dr Gareth Ackland; Prof Sir Salvador Moncada; Dr Mark Peters; Prof Tony Segal; Prof Derek Gilroy; Prof Hugh Montgomery; Prof Mervyn Singer; Prof John Martin; Prof Michael Duchen; Prof Arne Akbar; Prof Monty Mythen; Prof Mike Ehrenstein; Prof Lucie Clapp; Prof Steve Humphries; Prof Aroon Hingorani

External Collaborators

Publications

    2013

    • Bion J, Richardson A, Hibbert P, Beer J, Abrusci T, McCutcheon M, Cassidy J, Eddleston J, Gunning K, Bellingan G, Patten M, Harrison D, Matching Michigan Collaboration & Writing Committee (2013). 'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.. BMJ Qual Saf, 22(2), 110 - 123. doi:10.1136/bmjqs-2012-001325

    2012

    • Anderson P, Fee P, Shulman R, Bellingan G, Howell D (2012). Audit of audit: review of a clinical audit programme in a teaching hospital intensive care unit.. Br J Hosp Med (Lond), 73(9), 526 - 529.
    • Black CJ, Kuper M, Bellingan GJ, Batson S, Matejowsky C, Howell DC (2012). A multidisciplinary team approach to weaning from prolonged mechanical ventilation.. Br J Hosp Med (Lond), 73(8), 462 - 466.

    2011

    • Wilson AP, Smyth D, Moore G, Singleton J, Jackson R, Gant V, Jeanes A, Shaw S, James E, Cooper B, Kafatos G, Cookson B, Singer M, Bellingan G (2011). The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals.. Crit Care Med, 39(4), 651 - 658. doi:10.1097/CCM.0b013e318206bc66
    • Nunnally ME, Jaeschke R, Bellingan GJ, Lacroix J, Mourvillier B, Rodriguez-Vega GM, Rubertsson S, Vassilakopoulos T, Weinert C, Zanotti-Cavazzoni S, Buchman TG (2011). Targeted temperature management in critical care: a report and recommendations from five professional societies.. Crit Care Med, 39(5), 1113 - 1125. doi:10.1097/CCM.0b013e318206bab2

    2009

    • Khandavilli S, Wilson P, Cookson B, Cepeda J, Bellingan G, Brown J (2009). Utility of spa typing for investigating the local epidemiology of MRSA on a UK intensive care ward.. Journal of Hospital Infection, 71(1), 29 - 35.
    • Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T, Newson J, Bellingan G, Gilroy DW (2009). Effects of low-dose aspirin on acute inflammatory responses in humans.. J Immunol, 183(3), 2089 - 2096. doi:10.4049/jimmunol.0900477

    2008

    • Rajakariar R, Lawrence T, Bystrom J, Hilliard M, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW (2008). Novel biphasic role for lymphocytes revealed during resolving inflammation.. Blood, 111(8), 4184 - 4192. doi:10.1182/blood-2007-08-108936
    • Lagan AL, Quinlan GJ, Mumby S, Melley DD, Goldstraw P, Bellingan GJ, Hill MR, Briggs D, Pantelidis P, du Bois RM, Welsh KI, Evans TW (2008). Variation in iron homeostasis genes between patients with ARDS and healthy control subjects.. Chest, 133(6), 1302 - 1311. doi:10.1378/chest.07-1117

    2007

    • Wilson AP, Hayman S, Whitehouse T, Cepeda J, Kibbler C, Shaw S, Zelaya C, Cookson B, Singer M, Bellingan G (2007). Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study.. Critical Care Medicine, 35(10), 2275 - 2279. doi:10.1097/01.CCM.0000284504.89948.6E
    • Heightman M, Bellingan G (2007). acute respiratory medicine. Clinical Medicine, 7(3), 267 - 271.
    • Hayman S, Wilson AP, Singer M, Bellingan G (2007). Effect of linezolid and teicoplanin on skin staphylococci.. Journal of Antimicrobial Chemotherapy, 59(6), 1281 - 1282.
    • Rajakariar R, Hilliard M, Lawrence T, Colville-Nash P, Bellingan GF, D Y, M G, D (2007). Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy12-14PGJ2.. Proceedings of the National Academy of Sciences of the United States of America, 104(52), 20979 - 20984. doi:10.1073/pnas.0707394104
    • Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, Bellingan G (2007). TREM-1 promotes survival during septic shock in mice.. European Journal of Immunology, 37(2), 456 - 466.

    2006

    • Bellingan GJ, Al-Khafaji A (2006). Ventilator associated pneumonia. In Laurent GJ, Shapiro SD (Ed.), Encyclopedia of Respiratory Medicine (pp. 464 - 469). : Elsevier.
    • Wilson AP, Hayman S, Cepeda JA, Singer M, Bellingan G (2006). Screening for MRSA and GISA in the intensive care unit.. Journal of Hospital Infection, 64(1), 85 - 86.
    • Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G (2006). In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.. Journal of Antimicrobial Chemotherapy, 58(2), 470 - 473.
    • Woodhead M, Welch CA, Harrison DA, Bellingan GJ, Ayres JG (2006). Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Critical Care, 10(Suppl 2 S1), - .
    • Bellingan GJ (2006). Pulmonary Dysfunction in Sepsis. Advances in Sepsis, 5(2), 42 - 52.
    • Bellingan GJ, Finney S (2006). Acute Respiratory Distress Syndrome. In Laurent GJ, Shapiro S (Ed.), Encylcopedia of Respiratory Medicine (pp. 11 - 19). : Elsevier.
    • Wilson AP, Hayman S, Folan P, Ostro PT, Birkett A, Batson S, Singer M, Bellingan G (2006). Computer keyboards and the spread of MRSA. Journal of Hospital Infection, 62(3), 390 - 392.

    2005

    • Bellingan GJ (2005). Management of MRSA. ICU Management, 5(4), 40 - 41.
    • Ng J, Finney SJ, Shulman R, Bellingan GJ, Singer M, Glynne PA (2005). Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?. Br J Anaesth, 94(6), 774 - 777. doi:10.1093/bja/aei114
    • Ng J, Finney SJ, Shulman R, Bellingan GJ, Singer M, Glynne PA (2005). Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?. British Journal of Anaesthesia, 94(6), 774 - 777.
    • Tang JW, Eames I, Li Y, Taha YA, Wilson P, Bellingan G, Ward KN, Breuer J (2005). Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. Journal of Hospital Infection, 61(4), 277 - 366.
    • Shulman R, Singer M, Goldstone J, Bellingan G (2005). Medication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit.. Critical Care, 9(5), R516 - R521.
    • Bellingan G (2005). Hooray for Hypoxia?. PLoS Medicine, 2(6), e130 - . doi:10.1371/journal.pmed.0020130
    • Tang JW, Eames I, Li Y, Taha YA, Wilson P, Bellingan G, Ward KN, Breuer J (2005). Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows.. Journal of Hospital Infection, 61(4), 283 - 286.
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson AP (2005). Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. The Lancet, 365(9456), 295 - 304. doi:10.1016/S0140-6736(05)17783-6

    2004

    • Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W (2004). Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.. New England Journal of Medicine, 351(9), 884 - 892. doi:10.1056/NEJMoa033181
    • Farr BM, Bellingan G (2004). Pro/con clinical debate: isolation precautions for all intensive care unit patients with methicillin-resistant Staphylococcus aureus colonization are essential.. Critical Care, 8(3), 153 - 156.
    • Hodges RJ, Jenkins RG, Wheeler-Jones CPD, Copeman DM, Bottoms SE, Bellingan GJ, Nanthakumar CB, Laurent GJ, Hart SL, Foster ML, McAnulty RJ (2004). Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.. American Journal Of Pathology, 165(5), 1663 - 1676.
    • Bellingan G, Cepeda J, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Singer M, Wilson P (2004). Source Isolation in ICU Does Not Reduce Spread of MRSA: A Prospective Two-Centre Study.
    • Reyal Y, Bellingan G (2004). Molecular mechanisms of lung injury; pathological changes and physiological consequences. Surgery (series VI), 22(8), - .
    • Elrayess MA, Webb KE, Bellingan GJ, Whittall RA, Kabir J, Hawe E, Syvanne M, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Miller GJ, Humphries SE (2004). R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events.. Atherosclerosis, 177(1), 127 - 135.
    • Cuthbertson BH, Thompson M, Sherry A, Wright MM, Bellingan GJTICS (2004). The Intensive Care Society (2004) Antibiotic-treated infections in intensive care patients in the UK.. Anaesthesia, 59, 885 - 890.
    • Bellingan GJ (2004). The pathogenesis of Acute Lung Injury/Acute Respiratory Distress Syndrome. In (Ed.), In Respiratory Management in Critical Care (pp. - ). : BMJ Publishing.

    2003

    • Bellingan GJ (2003). Systemic sepsis syndromes. In Neuberger J (Ed.), Horizons in Medicine No. 14 (pp. 233 - 242). : Royal College of Physicians of London.
    • Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson APR (2003). Source isolation in intensive care units does not reduce spread of MRSA beyond that achieved by universal precautions: a prospective two-centre study.
    • Ghosh IR, Bellingan G (2003). Inflammation: cellular responses and cytokine production. Anaesthesia and Intensive Care Medicine, 4(6), 186 - 189.
    • Singer M, Bellingan G (2003). The use of oxygen in acute exacerbations of chronic obstructive pulmonary disease: a prospective audit of pre-hospital and hospital emergency management. Clinical Medicine, 3(2), 184 - 186.
    • Hails J, Kwaku F, Wilson AP, Bellingan G, Singer M (2003). Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Medicine, (29), 481 - 483.

    2002

    • Bellingan GJ (2002). Apoptosis and the resolution of inflammation in sepsis. In Vincent JL, Carlet J, Opal S (Ed.), The sepsis text (pp. 231 - 246). : Kluwer Academic Publishers.
    • Cepeda JA, Whitehouse T, Wilson APR, Singer M, Bellingan G, Kibbler C, Shaw S (2002). MRSA clearance during treatment with linezolid.
    • Bellingan GJ (2002). The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. THORAX, 57(6), 540 - 546.
    • Bellingan G, Smith MG, G (2002). Critical care medicine.. In Souhami RL, Moxham J (Ed.), Textbook of Medicine (pp. 725 - 750). : .
    • Tomlinson L, Bellingan GJ (2002). Trauma and Acute lung Injury.. The Journal of Trauma, 4, 147 - 157.
    • Sulaiman H, Dawson L, Laurent GJ, Bellingan GJ, Herrick SE (2002). Role of plasminogen activators in peritoneal adhesion formation. Biochemical Society Transactions, 30(2), 126 - 131.
    • Bellingan GJ, Xu P, Cooksley H, Cauldwell H, Shock A, Bottoms S, Haslett C, Mutsaers SE, Laurent GJ (2002). Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. Journal of Experimental Medicine, 196(11), 1515 - 1521. doi:10.1084/jem.20011794
    • Bellingan GJ (2002). Resolution of inflammation and repair. In (Ed.), Acute respiratory distress syndrome (pp. 70 - 82). : .
    • Cepeda JA, Whitehouse T, Wilson APR, Singer M, Bellingan G, Kibbler C, Shaw S (2002). MRSA clearance during treatment with Linezolid. [Abstract PS133]. European Congress of Chemotherapy, , - .
    • Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ (2002). Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 166(5), 646 - 650. doi:10.1164/rccm.2108086
    • Cepeda JA, Whitehouse T, Wilson APR, Singer M, Bellingan G, Kibbler C, Shaw S (2002). MRSA clearance during treatment with Linezolid.
    • Chua F, Bellingan G (2002). Acute REspiratory Distress Syndrome: fibrosis fast and furious. Clinical Intensive Care, 13(2), 7 - 13.

    2000

    • Chambers RC (2000). Role of Thrombin in Acute Lung Injury.. In Bellingan GJ, Laurent GJ (Ed.), Mechanisms of Acute Lung Injury (pp. 115 - 128). : IOS Press.
    • Bellingan G (2000). Leukocytes: friend or foe. Intensive Care Medicine, 26 Sup, S111 - S118.
    • Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ (2000). Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. American Journal of Respiratory and Critical Care Medicine, 162(5), 1783 - 1788.
    • Bellingan G, Olivier T, Batson S, Webb A (2000). Comparison of a specialist retrieval team with current UK practice for the transport of critically ill patients.. Intensive Care Medicine, 26, 740. - 744.
    • Wilson AP, Wright S, Bellingan G (2000). Disseminated fungal infection following falciparum malaria. Journal of Infection, 40(2), 202 - 204.
    • Bellingan GJ, Laurent GJ (2000). Acute Lung injury; from Inflammation to Repair..
    • Bellingan GM, R L, G (2000). Fibrosis in ARDS: how close is the link between inflammation and fibroproliferation?. In Vincent JL (Ed.), Yearbook of Intensive Care and Emergency Medicine (pp. 217 - 224). : Springer.

    • Sutkanan K, Bellingan G (). Surfactant Therapy. In Waldman C (Ed.), Oxford Desk REference:Critical Care (pp. - ). : O.U.P..
    • Schouten G, Bellingan G (). Severe Malaria. In Waldman C (Ed.), Oxford Desk Reference: Critical Care (pp. - ). : O.U.P..
    • Bellingan GD, K (). Artificial nutritional support in clinical practice - the critically ill patient. In Payne-James Grimble Forbes AS (Ed.), Artificial nutrition support in clinical practice (pp. - ). : .
    • Lagan A, Quinlan G, Mumby S, Goldstraw P, Bellingan GM, R H, M B, D D, R WK, Evans T (). Variation in Iron homeostasis genes between patients with acute respiratory distress syndrome and healthy controls. Chest, , - .
    • Cordery R, Roberts C, Cooper S, Bellingan G, Shetty N (). An evaluation of risk factors for the acquisition of blood stream infections with ESBL producing E. coli and Klebsiella species in the the intensive care unit; antibiotic managment and clinical outcome. Journal of Hospital Infection, , - .